Launch Africa’s playbook for managing one of Africa’s biggest VC portfolios

Three hundred ninety-eight venture capital deals closed in seven days. From May 26 through June 2, 2026, startup funding activity hit a pace unseen in recent quarters—an average of 57 deals per day, with May 27 alone seeing 87 announcements.

The deal volume tells one story. The composition tells another. Artificial intelligence dominates: 73 of the 398 deals (18%) involved AI startups or companies building AI infrastructure. But equally striking is the distribution of capital across round stages. Series A rounds—the traditional marker of product-market fit—are accelerating. So are seed rounds. And in the background, a $1 trillion IPO filing from Anthropic signals that the AI supercycle has entered the public markets.

Deal Velocity Is the Story

May 27 registered 87 deals, the highest single-day total of the week. May 29 followed with 80. Then the volume collapsed: just 26 deals on May 30 and only 7 on May 31—a weekend effect that recovered to 43 on June 1 and 34 on June 2. The pattern suggests a market operating at full throttle during business hours, with minimal spillover into weekends. No delays for due diligence or legal review. Pure velocity.

At this pace—57 deals per day, every business day—venture capital is deploying capital into 285+ new companies monthly. For context, that exceeds the total monthly deal count from many sectors in earlier quarters of 2026. The sheer volume is reshaping how capital markets function. When 400 deals happen in a week, portfolio construction becomes a numbers game, not a selection game. Venture firms are writing checks into a broader set of companies, betting that dominance in a category requires capturing more deal flow, not cherry-picking individual winners.

Artificial Intelligence Is Consuming Venture Capital

Seventy-three of 398 deals (18%) explicitly mentioned AI in their titles or sector classifications. But that number understates AI's actual share. Many deals categorized in "other" likely involved AI components—enterprise software rarely goes without an AI layer now. If AI-touched deals were counted, the share would easily exceed 25%.

The AI deals span multiple stages. Anthropic filed for IPO confidentially at nearly $1 trillion valuation, marking the sector's entry into mega-scale M&A. Smaller rounds clustered around series funding. Geordie AI raised £22.3 million for a security and governance platform for AI agents. Gradient Labs secured $13 million in fresh capital. Seed-stage AI companies pulled in millions alongside seven-figure institutional rounds. The AI category has absorbed so much venture capital that it functions as its own venture ecosystem—with seed, growth, and exit stages all operational simultaneously.

Series A Rounds Are Growing, Not Shrinking

A persistent narrative in venture capital over 2025 described a "missing middle"—a gap in Series A funding as companies either raised seed rounds and stayed private longer or jumped directly to later stages. The May 26–June 2 data contradicts that narrative. Thirty-four Series A rounds closed in one week. That's sustainable deal flow, not scarcity.

Other round types show different patterns. Seed rounds (30 deals) roughly matched Series A. Series B (10 deals) and Series C+ (9 deals) were rarer. IPOs and other public-market announcements (13 deals) suggest that unicorn exits are finally accelerating. The distribution indicates a market with ample early-stage capital and clearing mechanisms for mature companies, but concentrated competition at the growth stage.

Examples abound: Waypoint Bio raised $20 million in Series A. Saris secured $28.8 million in Series A funding. Countable Labs completed a $26 million funding round. These are meaningful checks—not mega-rounds, but sufficient to fund 24–36 months of product development and team expansion. This volume suggests confidence that the Series A companies will find customers, not just more capital.

Geography Extends Beyond the U.S.

While no single country dominated the deal count, international deals comprised a visible chunk of the 398. Geordie AI in the UK raised £22.3 million. Anveshan in India raised Rs 150 crore. Unastella, a South Korean rocket startup, raised $24 million. Lune & Wild in the UK raised £2 million to scale a children's food brand. The geographic diversification reflects both the global nature of AI and the expanded access to venture capital beyond Silicon Valley.

Sectors Beyond AI Remain Populated

Healthcare and biotech attracted 14 deals. Enterprise software commanded 12. Consumer companies drew 11. Climate and energy startups secured 5. While AI captures headlines—and capital—the rest of venture funding remains robust. No sector is starved; rather, AI is enjoying a surplus that may reflect genuine structural opportunity (adoption curves, regulatory tailwinds, unit economics) rather than mere hype.

Notable deals outside AI include Mach Industries, a defense tech company, hitting a $1.8 billion valuation after a 4x jump in one year. Paralign Health secured a $3 million seed round in healthcare. Ex-Meta CTO Mike Schroepfer's Gigascale Capital raised $250 million for a climate fund. These examples show that venture capital is flowing across multiple sectors, not bottlenecked into a single category.

What the Velocity Means

Four hundred deals in one week is not sustainable as a baseline. Markets cycle. Capital allocation follows valuations; valuations follow perceived risk. When May 30 and 31 produced only 33 combined deals, it suggested the market sensed a moment for pause, consolidation, or reassessment.

But the fact that the recovery came swiftly—43 and 34 deals on June 1 and 2—implies that the pause was brief. Venture capital firms are writing checks with conviction. Whether that conviction is justified depends on the companies' ability to execute, not the volume of funding. The next quarter will reveal whether this velocity translated into sustainable growth or a bunching of weak deals that future write-downs will expose.

For now, the data is clear: Venture capital in Q2 2026 is operating at a pace not seen in the previous two quarters. AI is leading. Series A is alive. And capital is flowing to founders globally, not just in coastal tech hubs.